Table 38: Objective Outcome Measures of Effectiveness. Transurethral Holmium Laser Enucleation of the Prostate (HoLEP) Versus Open Prostatectomy.
| Study, Year | Peak urinary flow (Qmax), Mean (SD), mL/s | Postvoid residual urine, Mean (SD), mL | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 3 months | 6 months | 1 year | > 1 year 18 months | Baseline | 3 months | 6 months | 1 year | > 1 year 18 months | |
| Kuntz et al. 2004 (73) HoLEP |
3.8 +/-3.6 | 27.6 +/-7.0 | 29.9 +/-8.8 | 27.4 +/-9.7 | 27.4 +/-10.6 28.0 +/-5.7 |
280 +/-273 | 7.2 +/-18.8 3.0 +/-7.7 |
4.4 +/-11.0 2.1 +/-6.0 |
5.8 +/- 16.7 6.4 +/-12.3 |
7.1 +/-19.6 6.0 +/-11.7 |
| Open | 3.6 +/-3.8 | 27.3 +/-6.2 | 27.0 +/-0.5 | 28.8 +/-7.5 | 292 +/- 191 | |||||
HoLEP refers to holmium laser enucleation of the prostate; NR, not reported; Open, open prostatectomy; Qmax, maximum urinary flow; SD, standard deviation